Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Recruiting

Phase 1

SGLT2 InhibitorsContinuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Sponsor:

McGill University

Code:

NCT06753994

Conditions

Diabetes

Type1diabetes

T1D

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SGLT-2 inhibitor

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by McGill University on 2024-12-31.